Get in Touch

AIM Biotech to Present at Biotech Showcase™ 2021; To Highlight Expansion of its Organ-on-a-Chip Business

Key Takeaways
  • CEO Jim McGorry will share the company's plan to expand its organ-on-a-chip business.
  • The company sells its chips directly to researchers and as a service to drug discovery organizations.
  • AIM's organ-on-a-chip helps researchers generate more predictive human data data  for drug discovery and development.

January 11, 2021 – AIM Biotech is participating in Biotech Showcase™ 2021, where CEO Jim McGorry will share the Company's plan to commercialize its organ-on-a-chip product line and contract research services. Registered attendees may access recorded company presentations prior to the event, schedule direct meetings and engage in Q&A with management. 

The AIM platform helps overcome the limitations of drug development when it comes to use of cell culture assays and animal models. By giving research teams more relevant, human-focused data at every stage of development, they can benefit from more informed decisions and less wasted time and money in drug development. All of this is possible using AIM's scalable organ-on-a-chip assays that are designed for plug-and-play functionality with existing lab equipment.

"In the past 15 years, new drug candidates have doubled, yet 90% have failed in clinical trials," said Jim McGorry, CEO of AIM Biotech. "Organ-on-a-chip technology is poised to help drug developers generate more predictive human data ahead of human studies and increase the success rate. Following our recent Series A, we are making plans to aggressively expand our organ-on-a-chip business, including the establishment of U.S. operations."

You can preview the deck that McGorry is presenting at the event here. Investors and press are eligible for a complimentary registration to the event, which will enable such attendees to view the full presentation and engage with the Company through the digital event's online platform.


ABOUT BIOTECH SHOWCASE
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year. Now in its 13th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.

ABOUT AIM BIOTECH
AIM Biotech's platform and world-class lab services let drug researchers get more relevant, human-focused data at every stage of development. That means more informed decisions and less wasted time. Streamline your workflow. Rethink how you look at life sciences. It's time to add the human element.

Key Takeaways
  • CEO Jim McGorry will share the company's plan to expand its organ-on-a-chip business.
  • The company sells its chips directly to researchers and as a service to drug discovery organizations.
  • AIM's organ-on-a-chip helps researchers generate more predictive human data data  for drug discovery and development.
Media Gallery
Related Bios
Jim McGorry
Chief Executive Officer
View Full Bio>>
Contacts
Media & Investors
aimbiotech@reportablenews.com